Skip NavigationSkip to Content

Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization

  1. Author:
    von Gegerfelt, A. S.
    Rosati, M.
    Alicea, C.
    Valentin, A.
    Roth, P.
    Bear, J.
    Franchini, G.
    Albert, P. S.
    Bischofberger, N.
    Boyer, J. D.
    Weiner, D. B.
    Markham, P.
    Israel, Z. R.
    Eldridge, J. H.
    Pavlakis, G. N.
    Felber, B. K.
  2. Author Address

    NCI, Human Retrovirus Sect, Vaccine Branch, Canc Res Ctr, Frederick, MD 21702 USA. NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Canc Res Ctr, Frederick, MD 21702 USA. NCI, Anim Models & Retroviral Vaccines Sect, Vaccine Branch, Ctr Canc Res, Bethesda, MD 20892 USA. NCI, Biometr Res Branch, Bethesda, MD 20892 USA. Gilead Sci Inc, Foster City, CA 94404 USA. Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA. Adv BioSci Labs Inc, Kensington, MD 20895 USA. Wyeth Vaccines Res, Pearl River, NY 10965 USA.;Pavlakis, GN, NCI, Human Retrovirus Sect, Vaccine Branch, Canc Res Ctr, 1050 Boyles St,Bldg 535,Room 210, Frederick, MD 21702 USA.;pavlakis@ncifcrf.gov
    1. Year: 2007
    2. Date: Feb
  1. Journal: Journal of Virology
    1. 81
    2. 4
    3. Pages: 1972-1979
  2. Type of Article: Article
  3. ISSN: 0022-538X
  1. Abstract:

    Rhesus macaques chronically infected with highly pathogenic simian immunodeficiency virus (SIV) SIVmac251 were treated with antiretroviral drugs and vaccinated with combinations of DNA vectors expressing SIV antigens. Vaccination during therapy increased cellular immune responses. After the animals were released from therapy, the virus levels of 12 immunized animals were significantly lower (P = 0.001) compared to those of 11 animals treated with only antiretroviral drugs. Vaccinated animals showed a persistent increase in immune responses, thus indicating both a virological and an immunological benefit following DNA therapeutic vaccination. Several animals show a long-lasting decrease in viremia, suggesting that therapeutic vaccination may provide an additional benefit to antiretroviral therapy.

    See More

External Sources

  1. DOI: 10.1128/jvi.01990-06
  2. WOS: 000244241400040

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel